SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001140361-24-026740
Filing Date
2024-05-17
Accepted
2024-05-17 17:22:12
Documents
51

Document Format Files

Seq Description Document Type Size
1 F-1/A ny20012777x11_f1a.htm F-1/A 2858627
2 EXHIBIT 1.1 ny20012777x11_ex1-1.htm EX-1.1 353612
3 EXHIBIT 3.1 ny20012777x11_ex3-1.htm EX-3.1 576954
4 EXHIBIT 3.2 ny20012777x11_ex3-2.htm EX-3.2 347533
5 EXHIBIT 4.1 ny20012777x11_ex4-1.htm EX-4.1 3462
6 EXHIBIT 5.1 ny20012777x11_ex5-1.htm EX-5.1 28669
7 EXHIBIT 10.5 ny20012777x11_ex10-5.htm EX-10.5 51701
8 EXHIBIT 10.6 ny20012777x11_ex10-6.htm EX-10.6 111149
9 EXHIBIT 10.22 ny20012777x11_ex10-22.htm EX-10.22 77437
10 EXHIBIT 10.23 ny20012777x11_ex10-23.htm EX-10.23 190997
11 EXHIBIT 10.24 ny20012777x11_ex10-24.htm EX-10.24 80360
12 EXHIBIT 10.25 ny20012777x11_ex10-25.htm EX-10.25 63058
13 EXHIBIT 10.26 ny20012777x11_ex10-26.htm EX-10.26 133320
14 EXHIBIT 10.27 ny20012777x11_ex10-27.htm EX-10.27 42086
15 EXHIBIT 10.28 ny20012777x11_ex10-28.htm EX-10.28 40194
16 EXHIBIT 23.2 ny20012777x11_ex23-2.htm EX-23.2 2313
17 EXHIBIT 99.1 ny20012777x11_ex99-1.htm EX-99.1 93891
18 EXHIBIT 99.2 ny20012777x11_ex99-2.htm EX-99.2 3216
19 EXHIBIT 99.3 ny20012777x11_ex99-3.htm EX-99.3 3972
20 EXHIBIT 99.4 ny20012777x11_ex99-4.htm EX-99.4 3962
21 logo_aprinoia.jpg GRAPHIC 35168
22 ny20012777x11_chart1x2.jpg GRAPHIC 209707
23 ny20012777x11_chart2x2.jpg GRAPHIC 306048
24 ny20012777x11_ex3-1img001.jpg GRAPHIC 7491
25 ny20012777x11_ex3-1img003.jpg GRAPHIC 17886
26 ny20012777x11_ex4-1slide1.jpg GRAPHIC 2574314
27 ny20012777x11_ex4-1slide2.jpg GRAPHIC 857716
28 ny20012777x11_ex5-1img001.jpg GRAPHIC 4265
29 ny20012777x11_ex5-1img002.jpg GRAPHIC 16805
30 ny20012777x11_graphic2.jpg GRAPHIC 182467
31 ny20012777x11_graphic5.jpg GRAPHIC 214868
32 ny20012777x11_graphic6.jpg GRAPHIC 200903
33 ny20012777x11_graphic7.jpg GRAPHIC 85730
34 ny20012777x11_graphic8.jpg GRAPHIC 125930
35 ny20012777x11_graphic9.jpg GRAPHIC 284714
36 ny20012777x11_graphic10.jpg GRAPHIC 49080
37 ny20012777x11_graphic11.jpg GRAPHIC 172796
38 ny20012777x11_graphic12.jpg GRAPHIC 54255
39 ny20012777x11_graphic13.jpg GRAPHIC 216003
40 ny20012777x11_graphic14.jpg GRAPHIC 166593
41 ny20012777x11_graphic15.jpg GRAPHIC 334012
42 ny20012777x11_graphic16.jpg GRAPHIC 237484
43 ny20012777x11_graphic17.jpg GRAPHIC 124160
44 ny20012777x11_graphic18x1.jpg GRAPHIC 76082
45 ny20012777x11_graphic19x1.jpg GRAPHIC 181676
46 ny20012777x11_graphic20x1.jpg GRAPHIC 206497
47 ny20012777x11_graphic-apn.jpg GRAPHIC 225128
48 ny20012777x11_graphic-mci.jpg GRAPHIC 86613
49 ny20012777x11_graphic-pft.jpg GRAPHIC 602838
50 ny20012777x11_graphic-tau.jpg GRAPHIC 297107
51 ny20012777x11_sc.jpg GRAPHIC 5929
  Complete submission text file 0001140361-24-026740.txt   16300931
Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 (724) 413-8794
APRINOIA Therapeutics Inc. (Filer) CIK: 0001998311 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1222
Type: F-1/A | Act: 33 | File No.: 333-276696 | Film No.: 24961400
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)